Fragile X syndrome is one of the most common inherited causes of intellectual disability, right below Down syndrome. How are basic science findings being translated into treatments for patients with neurodevelopment disorders, like Fragile X syndrome?
Tetra Therapeutics recently announced positive results from its Phase II exploratory study in adult patients with Fragile X syndrome.
But what is Fragile X syndrome, and what other research has been conducted around this neurodevelopmental disorder?
Elizabeth Berry-Kravis, MD, PhD, explains.
Dr Berry-Kravis is a pediatric neurologist at Rush University Medical Center.